The Cancer Research Institute and Chordoma Foundation established a research partnership to advance treatment options for chordoma, an ultra-rare cancer in the sarcoma family that occurs in the bones of the skull base and spine. CRI and the Chordoma Foundation will establish a joint fund to support chordoma-focused immunology grants awarded under CRI’s Clinic and Laboratory Integration Program (CLIP). CLIP grants provide catalytic support for translational laboratory studies designed to answer new specific scientific questions that arise in the clinic, with special focus on improving immunotherapy for cancer patients. 

The Chordoma Foundation is a nonprofit organization that serves the needs of the worldwide chordoma community, and partners with healthcare providers, scientists, and companies to improve the lives of those affected by chordoma and lead the search for a cure. The Foundation envisions a future in which everyone affected by chordoma is able to overcome the disease and maintain their quality of life. To achieve this vision, it invests in three core goals: better treatments, better care, and a better experience for everyone touched by chordoma. Since 2007, the Foundation has served thousands of chordoma patients around the world and dramatically accelerated the search for new therapies. 

*Immunotherapy results may vary from patient to patient.